CRISPR-and-Cas-Gene-Market
The Brainy Insights estimates that the USD 3.16 billion in 2023 global CRISPR and Cas Gene market will reach USD 15.60 billion by 2033. Cell and gene therapy is rapidly evolving, with CRISPR-Cas gene editing playing a central role in therapeutic development. Opportunities exist for developing CRISPR-modified cell therapies, including CAR-T cells, stem cell therapies, and engineered immune cells, for personalized and targeted treatments of cancer and genetic diseases.
Related Bookmarks
- RAN-Intelligent-Controller-Market
- Carbon-Wheels-Market
- Aspiration-Tubing-Market
- Biomass-Boiler-Market
- Food-Grade-Gases-Market
- Food-Traceability-Market
- Plant Based Sweeteners Market
- Power EPC market reach USD 1,103 Billion by 2033
- Talent Management Certification
- Trusted eCommerce Fulfilment Partner - Scale with Ease
Recent Profiles
Socolive
Monarch Roofing
C168
Shelley Mckay
So Thanh Chu
11w
Pg66
Sunwin M7hunet
Mu88
Amari Sawyer